Arvinas Inc. (NASDAQ: ARVN) stock closed at 88.61 per share at the end of the most recent trading day (a -5.92% change compared to the prior day closing price) with a volume of 309.97K shares and market capitalization of 4.36B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 133 people. Arvinas Inc. CEO is John Houston.

The one-year performance of Arvinas Inc. stock is 270.78%, while year-to-date (YTD) performance is 4.33%. ARVN stock has a five-year performance of %. Its 52-week range is between 19.68 and 108.46, which gives ARVN stock a 52-week price range ratio of 77.64%

Arvinas Inc. currently has a PE ratio of -26.30, a price-to-book (PB) ratio of 8.71, a price-to-sale (PS) ratio of 232.53, a price to cashflow ratio of 25.60, a PEG ratio of 2.32, a ROA of -36.09%, a ROC of -41.90% and a ROE of -41.91%. The company’s profit margin is -%, its EBITDA margin is -757.30%, and its revenue ttm is $20.90 Million , which makes it $0.40 revenue per share.

Of the last four earnings reports from Arvinas Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $3.90 for the next earnings report. Arvinas Inc.’s next earnings report date is 04th Nov 2021.

The consensus rating of Wall Street analysts for Arvinas Inc. is Strong Buy (1.22), with a target price of $128.64, which is +45.18% compared to the current price. The earnings rating for Arvinas Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Arvinas Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Arvinas Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 17.35, ATR14 : 4.13, CCI20 : -23.35, Chaikin Money Flow : 0.21, MACD : 1.21, Money Flow Index : 62.53, ROC : -3.56, RSI : 45.20, STOCH (14,3) : 23.15, STOCH RSI : 0.00, UO : 44.87, Williams %R : -76.85), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Arvinas Inc. in the last 12-months were: Bradley Margus (Sold 29 940 shares of value $2 545 168 ), Edward Kennedy (Buy at a value of $199 909), Ian Taylor (Option Excercise at a value of $823 296), Ian Taylor (Sold 45 894 shares of value $3 485 300 ), John G. Houston (Option Excercise at a value of $1 538 752), John G. Houston (Sold 98 037 shares of value $8 587 518 ), John Houston (Option Excercise at a value of $728 960), John Houston (Sold 44 000 shares of value $3 466 601 ), Liam Ratcliffe (Buy at a value of $9 999 990), Ronald Peck (Option Excercise at a value of $531 600), Ronald Peck (Sold 21 363 shares of value $1 670 391 ), Sean A. Cassidy (Option Excercise at a value of $733 744), Sean A. Cassidy (Sold 44 180 shares of value $3 464 123 )